Lead Sponsor

Centre Francois Baclesse

Age

45 - No limit years

Sex

FEMALE

Healthy Volunteers

Yes

•Patients aged 45 and over
•Patients from Grade 3 'end of primary schooling "minimum (scale Barbizet)
•Non-Metastatic Breast Cancer
•Adjuvant Chemotherapy: FEC, including Docetaxel Protocols
•No major cognitive impairment
•No previous neurological
•Lack of personality disorders and psychiatric disorders evolutionary
•Having signed the informed consent of study participation
•Women from the general population aged 45 and over, and matched in age and cultural level in patients
•Topics of Grade 3 'end of primary schooling "minimum (scale Barbizet)
•No prior cancer
•No major cognitive impairment
•No previous neurological
•Lack of personality disorders and psychiatric disorders evolutionary
•Participating in the IMAP Protocol No. ID-BCR: 2007-A00414-49 or IMAP+(n° ID RCB 2011-A01493-38)(see how the study below) have signed forms no objection and consent to study participation

•Traduction (français \> anglais)
•Metastatic
•Cancer of the breast other than primitive
•Patients with paraneoplastic syndrome
•Patients under 45 years
•Patients whose achievement is below level 3 'end of primary schooling "(scale Barbizet)
•Patients with adjuvant chemotherapy is associated with targeted therapy
•Patients who have received other cancer treatments (chemotherapy or radiotherapy brain)
•Contraindication to the implementation of an MRI (claustrophobia, metal objects in the body)
•disorders of higher functions existing in the administration of chemotherapy
•Neurologic earlier
•Pathology psychiatric evolutionary
•Refusal of participation
•Patients unable to meet the cognitive tests
•Drug use
•Heavy drinking

Related studies

NCT06347068 · Breast Cancer, Relapse, and more

NCT06631261 · Bronchiectasis Adult, Healthy Controls Group - Age and Sex-matched

NCT06500481 · Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, and more

NCT07655934 · Breast Cancer

NCT07436078 · Female Breast Cancer, Prostate Cancer, and more

Impact of Cancer on Memory Functioning: Understanding Disorders Using Approaches in Neuropsychology and Neuroimaging